Select Language

Press & media

MYoroface named one of the fastest growing companies in Europe

MYoroface, the Swedish healthtech company behind the IQoro, has been named one of the fastest growing companies in Europe. The award comes from the annual FT 1000 report developed by The Financial Times, which ranks European companies that have achieved the highest growth in recent years. In the UK, around 13 million people suffer from […]

Read more

IQoro on prescription

IQoro is available on prescription on the NHS from 1st May 2022. This means your GP can prescribe IQoro as a treatment, if they find it to be a suitable treatment for you. How to get IQoro on prescription IQoro is still a new device to many health professionals. Some might have heard of it briefly […]

Read more

Press images

Ylvali Gerling, VD på MYoroface AB
Ylvali Gerling, CEO and co-founder
Maria Gårdlund, COO på MYoroface AB
Maria Gårdlund, VP and COO
Linda Joneland, kommunikationschef på MYoroface AB
Linda Joneland, Communications Director

Press contact

Linda Joneland

0046-709-13 40 38

linda.joneland@myoroface.com